Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1990 Nov;53(11):994–997. doi: 10.1136/jnnp.53.11.994

Shy-Drager syndrome. Effect of fludrocortisone and L-threo-3,4-dihydroxyphenylserine on the blood pressure and regional cerebral blood flow.

S Matsubara 1, Y Sawa 1, H Yokoji 1, M Takamori 1
PMCID: PMC488283  PMID: 2283531

Abstract

In nine cases of Shy-Drager syndrome, the changes in blood pressure and cerebral blood flow on sitting up from a supine position were studied. The influence of fludrocortisone, a synthetic mineralocorticoid, and L-threo-3,4-dihydroxyphenylserine (DOPS), a precursor of norepinephrine, on these changes was examined. On sitting up, the regional cerebral blood flow (rCBF) measured by Xe133 inhalation showed a tendency to decrease. Fludrocortisone reduced the fall of the mean blood pressure significantly. DOPS reduced the fall of both the diastolic blood pressure and rCBF significantly.

Full text

PDF
994

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Araki H., Tanaka C., Fujiwara H., Nakamura M., Ohmura I. Pressor effect of L-threo-3,4-dihydroxyphenylserine in rats. J Pharm Pharmacol. 1981 Dec;33(12):772–777. doi: 10.1111/j.2042-7158.1981.tb13929.x. [DOI] [PubMed] [Google Scholar]
  2. Brooks D. J., Redmond S., Mathias C. J., Bannister R., Symon L. The effect of orthostatic hypotension on cerebral blood flow and middle cerebral artery velocity in autonomic failure, with observations on the action of ephedrine. J Neurol Neurosurg Psychiatry. 1989 Aug;52(8):962–966. doi: 10.1136/jnnp.52.8.962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Creveling C. R., Daly J., Tokuyama T., Witkop B. The combined use of alpha-methyltyrosine and threo-dihydroxyphenylserine--selective reduction of dopamine levels in the central nervous system. Biochem Pharmacol. 1968 Jan;17(1):65–70. doi: 10.1016/0006-2952(68)90158-5. [DOI] [PubMed] [Google Scholar]
  4. Dahlgren N., Rosén I., Sakabe T., Siesjö B. K. Cerebral functional, metabolic and circulatory effects of intravenous infusion of adrenaline in the rat. Brain Res. 1980 Feb 17;184(1):143–152. doi: 10.1016/0006-8993(80)90593-4. [DOI] [PubMed] [Google Scholar]
  5. Depresseux J. C., Rousseau J. J., Franck G. The autoregulation of cerebral blood flow, the cerebrovascular reactivity and their interaction in the Shy-Drager syndrome. Eur Neurol. 1979;18(5):295–301. doi: 10.1159/000115093. [DOI] [PubMed] [Google Scholar]
  6. Edvinsson L., Lacombe P., Owman C., Reynier-Rebuffel A. M., Seylaz J. Quantitative changes in regional cerebral blood flow of rats induced by alpha- and beta-adrenergic stimulants. Acta Physiol Scand. 1979 Dec;107(4):289–296. doi: 10.1111/j.1748-1716.1979.tb06478.x. [DOI] [PubMed] [Google Scholar]
  7. Fitch W., MacKenzie E. T., Harper A. M. Effects of decreasing arterial blood pressure on cerebral blood flow in the baboon. Influence of the sympathetic nervous system. Circ Res. 1975 Nov;37(5):550–557. doi: 10.1161/01.res.37.5.550. [DOI] [PubMed] [Google Scholar]
  8. Ishikawa Y., Kato Y., Murakami Y., Inoue T., Koshiyama H., Imura H. Effect of L-threo-3,4-dihydroxyphenylserine (L-DOPS) on catecholamine levels in plasma and cerebrospinal fluid (CSF) in anesthetized rats. Proc Soc Exp Biol Med. 1987 Feb;184(2):197–200. doi: 10.3181/00379727-184-42467. [DOI] [PubMed] [Google Scholar]
  9. Kachi T., Iwase S., Mano T., Saito M., Kunimoto M., Sobue I. Effect of L-threo-3,4-dihydroxyphenylserine on muscle sympathetic nerve activities in Shy-Drager syndrome. Neurology. 1988 Jul;38(7):1091–1094. doi: 10.1212/wnl.38.7.1091. [DOI] [PubMed] [Google Scholar]
  10. Kato T., Katsuyama M., Karai N., Nakamura M., Katsube J. Studies on the central action of L-threo-3,4-dihydroxyphenyl-serine (L-threo-DOPS) in FLA-63-treated mice. Pharmacol Biochem Behav. 1987 Feb;26(2):407–411. doi: 10.1016/0091-3057(87)90137-7. [DOI] [PubMed] [Google Scholar]
  11. Keaney N. P., Pickerodt V. W., McDowall D. G., Coroneos N. J., Turner J. M., Shah Z. P. Cerebral circulatory and metabolic effects of hypotension produced by deep halothane anaesthesia. J Neurol Neurosurg Psychiatry. 1973 Dec;36(6):898–905. doi: 10.1136/jnnp.36.6.898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Madsen J. B., Cold G. E., Hansen E. S., Bardrum B., Kruse-Larsen C. Cerebral blood flow and metabolism during isoflurane-induced hypotension in patients subjected to surgery for cerebral aneurysms. Br J Anaesth. 1987 Oct;59(10):1204–1207. doi: 10.1093/bja/59.10.1204. [DOI] [PubMed] [Google Scholar]
  13. Meyer J. S., Shimazu K., Fukuuchi Y., Ouchi T., Okamoto S., Koto A., Ericsson A. D. Cerebral dysautoregulation in central neurogenic orthostatic hypotension (Shy-Drager syndrome). Neurology. 1973 Mar;23(3):262–273. doi: 10.1212/wnl.23.3.262. [DOI] [PubMed] [Google Scholar]
  14. Narabayashi H., Kondo T., Yokochi F., Nagatsu T. Clinical effects of L-threo-3,4-dihydroxyphenylserine in cases of parkinsonism and pure akinesia. Adv Neurol. 1987;45:593–602. [PubMed] [Google Scholar]
  15. Nelson R. J., Lovick A. H., Pickard J. D., Brice J., Saunders D., Horsey P. J. Changes in cerebral blood flow during anaesthesia and surgery in the sitting position. J Neurol Neurosurg Psychiatry. 1987 Aug;50(8):971–975. doi: 10.1136/jnnp.50.8.971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Olesen J. Beta-adrenergic effects on cerebral circulation. Cephalalgia. 1986;6 (Suppl 5):41–46. doi: 10.1177/03331024860060S505. [DOI] [PubMed] [Google Scholar]
  17. Risberg J., Ali Z., Wilson E. M., Wills E. L., Halsey J. H. Regional cerebral blood flow by 133xenon inhalation. Stroke. 1975 Mar-Apr;6(2):142–148. doi: 10.1161/01.str.6.2.142. [DOI] [PubMed] [Google Scholar]
  18. Roland P. E., Eriksson L., Stone-Elander S., Widen L. Does mental activity change the oxidative metabolism of the brain? J Neurosci. 1987 Aug;7(8):2373–2389. [PMC free article] [PubMed] [Google Scholar]
  19. SCHIEVE J. F., WILSON W. P. The changes in cerebral vascular resistance of man in experimental alkalosis and acidosis. J Clin Invest. 1953 Jan;32(1):33–38. doi: 10.1172/JCI102707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. SHY G. M., DRAGER G. A. A neurological syndrome associated with orthostatic hypotension: a clinical-pathologic study. Arch Neurol. 1960 May;2:511–527. doi: 10.1001/archneur.1960.03840110025004. [DOI] [PubMed] [Google Scholar]
  21. Sato E., Irie T., Katsube J. Effect of L-threo-3,4-dihydroxyphenylserine (L-DOPS), an immediate precursor of norepinephrine, on the cerebral blood flow in rats. Jpn J Pharmacol. 1987 Jan;43(1):91–93. doi: 10.1254/jjp.43.91. [DOI] [PubMed] [Google Scholar]
  22. Schatz I. J. Current management concepts in orthostatic hypotension. Arch Intern Med. 1980 Sep;140(9):1152–1154. [PubMed] [Google Scholar]
  23. Suzuki T., Higa S., Sakoda S., Ueji M., Hayashi A., Takaba Y., Nakajima A. Pharmacokinetic studies of oral L-threo-3,4-dihydroxyphenylserine in normal subjects and patients with familial amyloid polyneuropathy. Eur J Clin Pharmacol. 1982;23(5):463–468. doi: 10.1007/BF00605999. [DOI] [PubMed] [Google Scholar]
  24. Thomas D. J., Bannister R. Preservation of autoregulation of cerebral blood flow in autonomic failure. J Neurol Sci. 1980 Jan;44(2-3):205–212. doi: 10.1016/0022-510x(80)90127-6. [DOI] [PubMed] [Google Scholar]
  25. Tuor U. I., Edvinsson L., McCulloch J. Catecholamines and the relationship between cerebral blood flow and glucose use. Am J Physiol. 1986 Oct;251(4 Pt 2):H824–H833. doi: 10.1152/ajpheart.1986.251.4.H824. [DOI] [PubMed] [Google Scholar]
  26. Ujike H., Yamamoto M. Effect of L-threo-3,4-dihydroxyphenylserine on regional cerebral blood flow in patients with Parkinson's disease. J Neurol Sci. 1988 Jan;83(1):75–80. doi: 10.1016/0022-510x(88)90021-4. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES